If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFXI.L Regulatory News (FXI)

  • There is currently no data for FXI

Revolution Analytics partnership

17 Mar 2014 07:00

RNS Number : 4281C
Fusionex International PLC
17 March 2014
 



For Immediate Release

17 March 2014

 

Fusionex International plc

("Fusionex", "the Company")

Revolution Analytics partners Fusionex to provide the R-Factor for GIANT

Fusionex (LSE: FXI), an award-winning and market leading international provider of enterprise software specialising in Analytics and Big Data solutions, is pleased to announce a technology partnership with Revolution Analytics ('Revolution'), a leading enterprise 'R' Big Data platform provider.

The alliance with Revolution is in line with Fusionex's plans to strengthen its Big Data channel market network and is in addition to two previously announced partnership agreements with Cloudera and Hortonworks.

The strategic partnership will help facilitate cross-referrals between Fusionex and Revolution's established client bases. By both integrating and combining the production-ready Revolution 'R' Enterprise programming platform with Fusionex's flagship Big Data Analytics product GIANT, potential customers will be able to obtain faster and more accurate predictive analytics whilst avoiding or reducing the time and cost impacts as well as complexity surrounding 'R' and Big Data.

Ivan Teh, Fusionex Managing Director commented:

"We are delighted to announce our new channel partner agreement with Revolution Analytics. This, alongside our existing agreements with Cloudera and Hortonworks will enable the Company to accelerate the roll out of our GIANT product offering globally. We look forward to working closely with Revolution Analytics and leveraging our Big Data market presence."

Laurence Liew, Revolution Analytics General Manager, APAC added:

"Fusionex's regional leadership in Business Intelligence and Big Data Analytics lends itself as an excellent partner for Revolution Analytics. We are very excited with this partnership and are confident that it will accelerate the adoption of Revolution and Fusionex's products and solutions in the region."

For further details:

Fusionex

Ivan Teh, Chief Executive Officer

Yuen Choong Lai, Chief Financial Officer

Through Buchanan

 

Panmure Gordon

Fred Walsh, Grishma Patel, Ben Roberts (Investment Banking)

Tom Nicholson, Charles Leigh-Pemberton (Corporate Broking)

020 7886 2500

Buchanan

Jeremy Garcia, Gabriella Clinkard

www.buchanan.uk.com

020 7466 5000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPDKFEALEFF
Date   Source Headline
28th Jan 20169:55 amRNSDirector's Share Dealing
28th Jan 20167:00 amRNSDirector's Share Dealing
26th Jan 201611:43 amRNSDirector's Share Dealing
22nd Jan 20167:30 amRNSStatement in response to share price movement
21st Jan 20167:00 amRNSPreliminary results
18th Jan 20167:00 amRNSMillion dollar Open Data contract win
13th Jan 20167:00 amRNSGIANT contract win with Asian hospital
12th Jan 201610:00 amRNSNotification of Full Year Results
1st Dec 201510:22 amRNSNotification of Major Interest in Shares
1st Dec 20157:00 amRNSGIANT Contract Win
13th Nov 20157:00 amRNSDell & Fusionex Enter Into a GIANT Partnership
15th Oct 20157:01 amRNSPlacing
15th Oct 20157:00 amRNSTrading Update
29th Sep 20154:31 pmRNSTransfer of Shares
24th Jun 20157:00 amRNSGIANT Contract Win with Takaful Insurance
27th May 20157:00 amRNSInterim Results
18th May 20157:00 amRNSGIANT Contract Win with Brother Industries
12th May 20157:01 amRNSNotification of Interim Results Results
5th May 20157:01 amRNSNew GIANT Partnership
30th Apr 20157:00 amRNSTrading Update
24th Mar 20157:00 amRNSGIANT Contract Win
18th Mar 20157:00 amRNSAppointment of Joint Broker
6th Mar 201512:38 pmRNSResult of AGM
11th Feb 20157:00 amRNSDividend Declaration
10th Feb 20157:00 amRNSPosting of Annual Report
5th Feb 20157:00 amRNSPreliminary results
13th Jan 20157:00 amRNSNotification of Full Year Results
18th Nov 20147:00 amRNSCapital Markets Day
31st Oct 201410:43 amRNSNotification of Capital Markets Day
24th Oct 201412:26 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Oct 20147:00 amRNSTrading Update
11th Sep 20147:30 amRNSDouble Awards
6th Aug 20141:30 pmRNSAIM Disclosure Update
24th Jun 20147:00 amRNSTechnology Alliance
23rd May 20144:25 pmRNSDirector's Share Dealing
21st May 20147:00 amRNSInterim Results
28th Apr 20147:00 amRNSTrading Update
17th Mar 20147:00 amRNSRevolution Analytics partnership
11th Mar 20147:00 amRNSFusionex secures further GIANT contract wins
10th Mar 20147:00 amRNSAGM Statement
11th Feb 20147:00 amRNSPosting of Annual Report
29th Jan 20147:00 amRNSFusionex secures first 'GIANT' contract win
28th Jan 20147:00 amRNSDividend Declaration
15th Jan 20147:00 amRNSPreliminary results
8th Jan 20147:00 amRNSNotification of Full Year Results
11th Dec 20137:00 amRNSProduct launch
6th Dec 20137:00 amRNSFusionex Wins Award
7th Oct 20137:00 amRNSTrading Update
13th Aug 20137:00 amRNSMicrosoft Business Intelligence Award
21st May 20137:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.